(1)
S, A. .; Rao, V. M. .; P. R, S. A Prospective Cross-Sectional Study to Evaluate the Utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) Patients in a Tertiary Care Center. J Neonatal Surg 2025, 14, 848-854.